Ibutilide
Potentially Fatal Arrhythmias
Experienced Personnel/Equipped Facility
Potentially Fatal Arrhythmias: have occurred and requires administration in a setting of continuous ECG monitoring and personnel trained in identification and treatment of acute ventricular arrhythmias.
Patient Selection: Patients with chronic atrial fibrillation have a strong tendency to revert after conversion to sinus rhythm and treatment to maintain sinus rhythms carry risks. Patients for ibutilide therapy should be carefully selected.
Monitoring data
- Patients with atrial fibrillation of > 2 to 3 days must be adequately anticoagulated for > 2 weeks
- Assess benefit/risk ratio of maintenance therapy
Patient counseling
Package inserts
Additional information
Updated: January 2018